Published in Lab Invest on March 08, 2010
SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis. Br J Cancer (2014) 1.03
SCCA1/SERPINB3 promotes oncogenesis and epithelial-mesenchymal transition via the unfolded protein response and IL6 signaling. Cancer Res (2014) 0.93
Glucose and fatty acid metabolism in a 3 tissue in-vitro model challenged with normo- and hyperglycaemia. PLoS One (2012) 0.90
Hepatic progenitor cells express SerpinB3. BMC Cell Biol (2014) 0.89
SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I. Oncotarget (2014) 0.88
Macrophage secretory products induce an inflammatory phenotype in hepatocytes. World J Gastroenterol (2012) 0.78
SERPINB3 is associated with longer survival in transgenic mice. Sci Rep (2013) 0.76
SERPINB3 (serpin peptidase inhibitor, clade B (ovalbumin), member 3). Atlas Genet Cytogenet Oncol Haematol (2015) 0.75
Clinical applications of squamous cell carcinoma antigen-immunoglobulins M to monitor chronic hepatitis C. World J Hepatol (2015) 0.75
Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles. Bioconjug Chem (2016) 0.75
Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med (2004) 5.68
Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites. J Hepatol (2013) 4.24
Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity (2010) 3.88
How to improve care in outpatients with cirrhosis and ascites: a new model of care coordination by consultant hepatologists. J Hepatol (2013) 3.75
A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J (2007) 2.76
Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax (2010) 2.60
Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol (2003) 2.46
Non-travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics. J Infect Dis (2005) 2.18
Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study. J Hepatol (2008) 2.14
Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation (2003) 2.12
Concealed metastatic lung carcinoma presenting as acute coronary syndrome with progressive conduction abnormalities. Circulation (2012) 2.10
A novel genotype of hepatitis E virus prevalent among farmed rabbits in China. J Med Virol (2009) 2.02
The association of HBV core promoter double mutations (A1762T and G1764A) with viral load differs between HBeAg positive and anti-HBe positive individuals: a longitudinal analysis. J Hepatol (2008) 1.76
Pathology of pulmonary antibody-mediated rejection: 2012 update from the Pathology Council of the ISHLT. J Heart Lung Transplant (2013) 1.71
Nonatopic children with multitrigger wheezing have airway pathology comparable to atopic asthma. Am J Respir Crit Care Med (2008) 1.67
Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant. Antivir Ther (2008) 1.63
Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J Infect Dis (2008) 1.59
Epithelial damage and angiogenesis in the airways of children with asthma. Am J Respir Crit Care Med (2006) 1.58
HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study. Am J Gastroenterol (2008) 1.53
Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm. Am J Respir Crit Care Med (2015) 1.52
Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J Immunol (2003) 1.51
Acute rejection and graft survival in renal transplanted patients with viral diseases. Mod Pathol (2004) 1.51
Comparison between two high-dose methylprednisolone schedules in the treatment of acute hepatic cellular rejection in liver transplant recipients: a controlled clinical trial. Liver Transpl (2002) 1.50
Characteristics of minimal hepatic encephalopathy. Metab Brain Dis (2004) 1.47
A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology (2004) 1.47
Heterotopic cardiac xenotransplantation in rodents: report of a refined technique in a hamster-to-rat model. Microsurgery (2005) 1.47
Cognitive impairment and electroencephalographic alterations before and after liver transplantation: what is reversible? Liver Transpl (2014) 1.46
Acute biopsy-proven lymphocytic myocarditis mimicking Takotsubo cardiomyopathy. Eur J Heart Fail (2009) 1.44
Prevalence, isolation, and partial sequence analysis of hepatitis E virus from domestic animals in China. J Med Virol (2002) 1.43
Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis. J Leukoc Biol (2007) 1.37
The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenase. Cell Metab (2013) 1.36
Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features. Hepatology (2007) 1.34
Arrhythmogenic right ventricular cardiomyopathy causing sudden cardiac death in boxer dogs: a new animal model of human disease. Circulation (2004) 1.33
Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma. J Allergy Clin Immunol (2012) 1.28
Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study. Hepatology (2006) 1.27
Hyperforin inhibits cancer invasion and metastasis. Cancer Res (2004) 1.27
Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study. J Gen Virol (2008) 1.26
2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc Pathol (2011) 1.24
Airway inflammation in childhood asthma. Am J Respir Crit Care Med (2003) 1.21
Core promoter mutations (A(1762)T and G(1764)A) and viral genotype in chronic hepatitis B and hepatocellular carcinoma in Guangxi, China. J Med Virol (2002) 1.20
Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis. Am J Respir Crit Care Med (2005) 1.19
Improving the inhibitory control task to detect minimal hepatic encephalopathy. Gastroenterology (2010) 1.14
Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects. Oral Oncol (2012) 1.10
Over-expression of SERPINB3 in hepatoblastoma: a possible insight into the genesis of this tumour? Eur J Cancer (2011) 1.10
Biological and clinical implications of HBV infection in peripheral blood mononuclear cells. Autoimmun Rev (2008) 1.08
Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients. Hepatology (2006) 1.06
Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection. Ann Intern Med (2002) 1.05
Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost (2005) 1.04
Comparison of real-time fluorescent RT-PCR and conventional RT-PCR for the detection of hepatitis E virus genotypes prevalent in China. J Med Virol (2007) 1.04
11,12-epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells. Prostaglandins Other Lipid Mediat (2006) 1.03
Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology. Prostaglandins Other Lipid Mediat (2003) 1.03
Attention dysfunction in cirrhotic patients: an inquiry on the role of executive control, attention orienting and focusing. Metab Brain Dis (2005) 1.02
Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase. Am J Physiol Heart Circ Physiol (2006) 1.01
Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma. Cancer (2005) 1.00
SERPINB3 induces epithelial-mesenchymal transition. J Pathol (2010) 1.00
The serological prevalence and genetic diversity of hepatitis E virus in farmed rabbits in China. Infect Genet Evol (2011) 1.00
Seroepidemiology and genetic characterization of hepatitis E virus in the northeast of China. Infect Genet Evol (2009) 0.99
Endoscopic screening for esophageal varices in cirrhotic patients. Hepatology (2002) 0.99
SERPINB3, apoptosis and autoimmunity. Autoimmun Rev (2009) 0.99
Detection of HEV antigen as a novel marker for the diagnosis of hepatitis E. J Med Virol (2006) 0.97
Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats. J Pharmacol Exp Ther (2007) 0.97
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids. Endocr Relat Cancer (2010) 0.97
Experimental infection of rabbits with rabbit and genotypes 1 and 4 hepatitis E viruses. PLoS One (2010) 0.96
A novel insight into adaptive immunity in chronic obstructive pulmonary disease: B cell activating factor belonging to the tumor necrosis factor family. Am J Respir Crit Care Med (2010) 0.96
Change in portal flow after liver transplantation: effect on hepatic arterial resistance indices and role of spleen size. Hepatology (2002) 0.95
Successful resection of a giant primary liposarcoma of the posterior mediastinum. J Thorac Oncol (2007) 0.95
Endomyocardial fibrosis: pathological and molecular findings of surgically resected ventricular endomyocardium. Virchows Arch (2008) 0.95
Depression, anxiety and alexithymia symptoms are major determinants of health related quality of life (HRQoL) in cirrhotic patients. Metab Brain Dis (2013) 0.94
Distant metastases from head and neck squamous cell carcinoma. Part III. Treatment. Oral Oncol (2012) 0.94
Expression of the atypical chemokine receptor D6 in human alveolar macrophages in COPD. Chest (2013) 0.93
Serpins, immunity and autoimmunity: old molecules, new functions. Clin Rev Allergy Immunol (2013) 0.93
Fc gamma RIIIb allele-sensitive release of alpha-defensins: anti-neutrophil cytoplasmic antibody-induced release of chemotaxins. J Immunol (2003) 0.93
Detection of prostate-specific antigen coupled to immunoglobulin M in prostate cancer patients. Cancer Detect Prev (2007) 0.92
Successful treatment of enterovirus-induced myocarditis with interferon-alpha. J Heart Lung Transplant (2003) 0.91
Impairment of response inhibition precedes motor alteration in the early stage of liver cirrhosis: a behavioral and electrophysiological study. Metab Brain Dis (2005) 0.91
Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma. Int J Cancer (2006) 0.91